Avid Bioservices to Exhibit at the 2018 BioProcess International Conference & Exhibition
August 28 2018 - 8:05AM
Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated
biologics contract development and manufacturing organization
(CDMO) working to improve patient lives by providing high quality
development and manufacturing services to biotechnology and
pharmaceutical companies, today announced that the company will
exhibit at the upcoming 2018 BioProcess International Conference
& Exhibition. Avid will host a corporate booth (#938) in the
conference’s exhibit hall, where it will showcase the company’s
comprehensive range of process development, high quality cGMP
clinical and commercial manufacturing services. The 2018 BioProcess
International Conference & Exhibition is being held September
4-7, 2018 in Boston, MA.
As part of its exhibit, Avid will provide a
virtual tour of the company’s 42,000 square foot state-of-the-art
commercial biomanufacturing suite (Myford facility), which is in
the unique position of being a validated facility with immediately
available 2,000-liter scale bioreactor capacity. The company will
also discuss the ongoing expansion of its process development
capabilities and laboratories.
The Myford facility, located in Tustin,
California, incorporates a variety of cutting-edge, single-use
equipment with the goal of ultimately accommodating a fully
disposable biomanufacturing process. A wide range of innovative
features are incorporated into the facility including monolithic
modular clean rooms, dedicated support utilities for each key
processing area, and the industry’s most advanced single-use
production systems and flexible solutions. Uni-directional process
flows separate personnel and materials and provide assurance that
the design meets the most stringent regulatory requirements for
commercial biologics drug substance manufacturing. This facility
complements Avid’s legacy commercial facility, located on the same
campus, which continues to be responsible for the manufacture
of multiple globally marketed commercial products.
For
more information on the 2018 BioProcess International Conference
& Exhibition, please visit:
https://lifesciences.knect365.com/bioprocessinternational/
About Avid Bioservices,
Inc.Avid Bioservices is a dedicated contract development
and manufacturing organization (CDMO) focused on development and
cGMP manufacturing of biopharmaceutical products derived from
mammalian cell culture. The company provides a comprehensive range
of process development, high quality cGMP clinical and commercial
manufacturing services for the biotechnology and biopharmaceutical
industries. With 25 years of experience producing monoclonal
antibodies and recombinant proteins in batch, fed-batch and
perfusion modes, Avid's services include cGMP clinical and
commercial product manufacturing, purification, bulk packaging,
stability testing and regulatory strategy, submission and support.
The company also provides a variety of process development
activities, including cell line development and optimization, cell
culture and feed optimization, analytical methods development and
product characterization. www.avidbio.com
Contacts:
Kelly Pisarev Lord
Avid Bioservices, Inc
(800) 987-8256
Stephanie Diaz (Investors)
Vida Strategic Partners
415-675-7401
sdiaz@vidasp.com
Tim Brons (Media)
Vida Strategic Partners
415-675-7402
tbrons@vidasp.com
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Sep 2023 to Sep 2024